Table of Contents

TYRX, Inc.
Year Started: 1998
Primary Investigator(s): Joachim B. Kohn, Ph.D. - Department of Chemistry & Chemical Biology, School of Arts and Sciences
Location: Monmouth Junction, NJ
TyRx Pharma, Inc. focuses on creating unique, cost-effective solutions that address surgical-site infections (SSIs) and inflammatory tissue-reaction associated with implanted medical devices. TYRX utilizes novel polymer technology, including a world-wide license from Rutgers University, covering a broad range of resorbable materials and drug delivery technology.

Successful Exit: Acquired by Medtronic in 2014

No files attached to this page.

Add a New Comment